Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Lowell Larew

Physician Assistant, Medical Morgantown, WV Physician Assistant

NPI 1265616841 CMS profile 11138751

3000 Mon Health Medical Park Dr Ste 3201, Morgantown, WV 26505

Open in the dashboard

General payments

$30,748

156 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lowell Larew of Morgantown, WV is reported in the CMS Open Payments database as having received $30,748 across 156 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,981 40
2024 General $9,433 30
2023 General $4,708 30
2022 General $5,884 21
2021 General $3,742 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lowell Larew
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Lowell Larew were reported at $6,981. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Lowell Larew Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $3,742 $156 $41–$563 $132
2022 $5,884 $185 $55–$649 $149
2023 $4,708 $199 $58–$717 $160
2024 $9,433 $206 $62–$740 $164
2025 $6,981 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Organogenesis Inc. $28,797 85 payments
  2. Melinta Therapeutics, Inc. $502 12 payments
  3. Cumberland Pharmaceuticals, Inc. $198 7 payments
  4. ETS Wound Care LLC $188 3 payments
  5. Misonix Inc $178 6 payments
  6. Paratek Pharmaceuticals, Inc. $172 5 payments
  7. Shionogi Inc $149 3 payments
  8. AbbVie, Inc. $91 6 payments
  9. Smith+Nephew, Inc. $89 6 payments
  10. Reprise Biomedical, Inc. $76 3 payments
  11. Other $308 20 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $22,693 17 payments
  2. Food and Beverage $3,738 123 payments
  3. Consulting Fee $2,575 3 payments
  4. Travel and Lodging $1,742 13 payments
Products named General payments · program years 2021–2025
  1. PURAPLY WOUND MATRIX $15,479 27 payments
  2. Puraply $5,983 22 payments
  3. Puraply Antimicrobial $5,355 18 payments
  4. Affinity $2,299 6 payments
  5. NuShield $890 4 payments
  6. APLIGRAF $720 3 payments
  7. NOVACHOR $706 2 payments
  8. Kimyrsa $502 12 payments
  9. VIBATIV $198 7 payments
  10. NUZYRA $172 5 payments
  11. Other $1,349 80 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

388

Median for Physician Assistant: 241

Drug cost

$164,292

Median for Physician Assistant: $4,110

Branded share of claims

30.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Daptomycin Generic 65 $96,156
Ertapenem Ertapenem Sodium Brand 39 $25,593
Oxacillin Sodium Generic 17 $14,877
Meropenem Generic 17 $7,551
Cefepime Hcl Generic 24 $4,779
Rifampin Generic 32 $4,542
Ceftriaxone Ceftriaxone Sodium Brand 42 $2,988
Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam Brand 11 $2,902
Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod Brand 11 $2,640
Dicloxacillin Sodium Generic 17 $961

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$124,397

Medicare's payments for the services billed

Medicare patients

437

Average age 76

Services billed

1,977

226 women, 211 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Diabetes 53%
Ischemic heart disease 51%
Chronic kidney disease 49%
Heart failure 44%
Atrial fibrillation 43%
COPD 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Kimyrsa
  • Melinta Therapeutics, Inc. $129
$129 — —
Fetroja
  • Shionogi Inc $53
$53 — —
Rezzayo
  • Melinta Therapeutics, Inc. $23
$23 — —
Vabomere
  • Melinta Therapeutics, Inc. $13
$13 — —
GARDASIL 9
  • Merck Sharp & Dohme Corporation $5
$5 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

156 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record